These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11833570)

  • 21. Ethics. Human health research ethics.
    Silbergeld E; Lerman S; Hushka L
    Science; 2004 Aug; 305(5686):949. PubMed ID: 15310879
    [No Abstract]   [Full Text] [Related]  

  • 22. Research examines the minimal risk standard for pediatric research.
    Luu AD
    J Biolaw Bus; 2006; 9(1):52-3. PubMed ID: 17111528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmaceutical industry's responsibility for protecting human subjects of clinical trials in developing nations.
    Kelleher F
    Columbia J Law Soc Probl; 2004; 38(1):67-106. PubMed ID: 16755695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rules of the game: institutional review boards.
    Lubowitz JH; Poehling GG; Burkhart SS
    Arthroscopy; 2008 Apr; 24(4):373-4. PubMed ID: 18375265
    [No Abstract]   [Full Text] [Related]  

  • 25. IRBs: going too far or not far enough?
    Felten DL
    Science; 2006 Sep; 313(5792):1388-9; author reply 1388-9. PubMed ID: 16959990
    [No Abstract]   [Full Text] [Related]  

  • 26. Thinking further about value: commentary on "A taxonomy of value in clinical research".
    Grady C
    IRB; 2002; 24(6):7-8. PubMed ID: 12683395
    [No Abstract]   [Full Text] [Related]  

  • 27. Bioethics Convention protocol on research.
    Bull Med Ethics; 2004 Aug; (200):7-11. PubMed ID: 15832479
    [No Abstract]   [Full Text] [Related]  

  • 28. New review burdens will affect many institutional review boards (IRBs).
    Maloney DM
    Hum Res Rep; 2001 Jul; 16(7):9. PubMed ID: 11933956
    [No Abstract]   [Full Text] [Related]  

  • 29. In harm's way: research subjects who are decisionally impaired.
    Sundram CJ
    J Health Care Law Policy; 1998; 1(1):36-65. PubMed ID: 15573429
    [No Abstract]   [Full Text] [Related]  

  • 30. The National Bioethics Advisory Commission: bridging the gaps in human subjects research protection.
    Childress JF
    J Health Care Law Policy; 1998; 1(1):105-22. PubMed ID: 15573433
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessing benefits in clinical research: why diversity in benefit assessment can be risky.
    Churchill LR; Nelson DK; Henderson GE; King NM; Davis AM; Leahey E; Wilfond BS
    IRB; 2003; 25(3):1-8. PubMed ID: 14569987
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhancing protections for human participants in clinical and health services research: a continuing process.
    Feussner JR; Burris JF; McGlynn G; Lavori PW
    Med Care; 2002 Sep; 40(9 Suppl):V4-11. PubMed ID: 12226580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Making more sense of "minimal risk".
    Barnbaum D
    IRB; 2002; 24(3):10-3. PubMed ID: 12848183
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessing the quality of human research protection programs to improve protection of human subjects participating in clinical trials.
    Tsan MF; Tsan LW
    Clin Trials; 2015 Jun; 12(3):224-31. PubMed ID: 25631384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioethical malpractice: risk and responsibilities in human research.
    Noah BA
    J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
    [No Abstract]   [Full Text] [Related]  

  • 36. Module five: implementation of ethics review.
    Dhai A
    Dev World Bioeth; 2005 Mar; 5(1):73-91. PubMed ID: 15748179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethical oversight of research in developing countries.
    Kass N; Dawson L; Loyo-Berrios NI
    IRB; 2003; 25(2):1-10. PubMed ID: 12833901
    [No Abstract]   [Full Text] [Related]  

  • 38. Instead of revising half the story, why not rewrite the whole thing?
    Taylor HA
    Am J Bioeth; 2007 Mar; 7(3):19-21. PubMed ID: 17366224
    [No Abstract]   [Full Text] [Related]  

  • 39. Protection of health research participants in the United States: a review of two cases.
    Douglass A; Crampton P
    N Z Bioeth J; 2004 Jun; 5(2):6-12. PubMed ID: 15597497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creative solutions: research subject advocates: increase in reports of human subject protection deficiencies bring scrutiny as well as more efforts at education and support.
    O'Lonergan T
    Prot Hum Subj; 2003; (8):10-1. PubMed ID: 16178110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.